Blood pressure and risk of prostate cancer: cohort Norway (CONOR)

  title={Blood pressure and risk of prostate cancer: cohort Norway (CONOR)},
  author={Richard M. Martin and Lars Johan Vatten and David Gunnell and P{\aa}l Richard Romundstad},
  journal={Cancer Causes \& Control},
BackgroundSome studies suggest that raised blood pressure may increase prostate cancer risk. We investigated associations of blood pressure with prostate cancer within the CONOR collaborative cohorts of Norway.MethodsBetween 1994 and 2003, 82,098 men from ten population-based cohorts in Norway completed standardised questionnaires and physical examinations, including resting blood pressure. The unique 11-digit identification number of Norwegian citizens allowed linkage with the Cancer Registry… 

Midlife metabolic factors and prostate cancer risk in later life

A positive association between midlife hypertension and diabetes and risk of total and aggressive prostate cancer is suggested and metabolic syndrome as a combination of factors was associated with an increased risk of fatal prostate cancer.

The association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case–control study

The authors' large population-based study generally does not support decreased risk of prostate cancer among antihypertensive drug users, and an increased overall prostate cancer risk was observed.

The significance of biological, environmental, and social risk factors for prostate cancer in a cohort study in Brazil.

Risk factors associated with an increased prevalence of prostate cancer in this cohort included increasing age and African ethnicity.

Asthma and Risk of Prostate Cancer

The results of this study suggest that men with asthma have an increased risk of prostate cancer.

Metabolic predispositions and increased risk of colorectal adenocarcinoma by anatomical location: a large population-based cohort study in Norway.

Significant associations between single MetS components and CA, except for reduced high-density lipoprotein cholesterol and nonfasting glucose levels, were observed.

The Prevalence of Cardiac Risk Factors in Men with Localized Prostate Cancer Undergoing Androgen Deprivation Therapy in British Columbia, Canada

Patients receiving ADT have a high prevalence of cardiovascular disease and risk factors and are more likely to be hypertensive than population controls and low rates of CV risk screening suggest opportunities for improved primary and secondary prevention of CV disease in this population.

Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies

It is suggested that hypertensive individuals may also be at higher risk of colorectal and breast cancer, but careful interpretation is required as most meta-analyses included relatively small number of studies, several relative risks had weak or moderate magnitude and maybe affected by residual confounding.

Warfarin use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer

This study, which included a larger number of PCa cases with warfarin exposure than previous studies, does not support previous notions of decreased risk of PCan users, and no difference in risk was found between war Farfarin and other anticoagulants.

Prevalence and Factors Associated with High Concentration of Prostate-Specific Antigen: ELSIA Study

A high prevalence of high PSA concentrations in the elderly is found and several aspects are associated, which can be a worrying factor for their health, since PSA is an important marker of prostate cancer.

Risk factors for prostate cancer: An hospital-based case-control study from Mumbai, India

The study revealed that there was no significant excess risk for chewers, alcohol drinkers, tea and coffee drinkers, family history of cancer, diabetes, vasectomy and dietary factors, however, patients with BMI >25, those with hypertension history and age >55 years had enhanced risk for prostate cancer.



Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway

Little evidence is found to support the hypothesis that the metabolic syndrome or its components explains higher prostate cancer mortality rates in countries with a “western” diet and lifestyle.

Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort

Results do not support the hypothesis that anti-hypertensive medication is strongly associated with risk of prostate cancer, and confounding by concurrent illness may explain inverse associations seen in other studies.

Heart rate and prostate cancer mortality: results of a prospective analysis.

  • P. GannM. DaviglusA. DyerJ. Stamler
  • Medicine
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 1995
The results are consistent with the hypothesis that local neurotrophic factors associated with sympathetic activity influence the progression of prostate cancer and could prove important even if due to an unmeasured etiological factor other than heart rate itself.

Recreational physical activity and risk of prostate cancer: A prospective population‐based study in Norway (the HUNT study)

Recreational physical exercise is associated with reduced risk of advanced prostate cancer and prostate cancer death, and frequency and duration of exercise were inversely associated with the risk ofadvanced prostate cancer.

Height and Prostate Cancer Risk: A Large Nested Case-Control Study (ProtecT) and Meta-analysis

Data indicate a limited role for childhood environmental exposures—as indexed by adult height—on prostate cancer incidence, while suggesting a greater role for progression, through mechanisms requiring further investigation.

Risk factors for prostate cancer incidence and progression in the health professionals follow‐up study

Although the proportion of advanced stage cancers was much lower after PSA screening began, risk factors for advanced stage prostate cancers were similar in the pre‐PSA and PSA era.


Cohort Profile: Cohort of Norway (CONOR)

A number of large population-based cardiovascular surveys have been conducted in Norway since the beginning of the 1970s, thus an important background for the Cohort of Norway (CONOR), a cohort including both core survey data and stored blood samples established in 2002.